Scott Kanner

Co-Founder & Head of Platform Development at Stablix

Scott is driven by targeting common vulnerabilities in disease, with over 10 years of research experience across areas of pharmacology, physiology, cell biology, molecular biology, and protein engineering. He is co-inventor of the company’s foundational platform and heads the research and development of platform technologies at Stablix. As a training physician-scientist at the Medical Scientist Training Program (MSTP) at Columbia University’s Vagelos College of Physicians & Surgeons, Scott received his PhD in Neuroscience and the NIH National Research Service Award.

Links